| DHER34 Stock | | | BRL 52.42 0.05 0.1% |
President
Mr. Brian W. Ellis is Senior Vice President, Chief Compliance Officer, General Counsel since joining Danaher in January 2016. Prior to joining Danaher, Mr. Ellis served for over five years in progressively more responsible positions in the legal department of Medtronic, Inc., a medical device company, including most recently as Vice President and General Counsel of Medtronics Restorative Therapies Group. since 2018.
| Age | 52 |
| Tenure | 6 years |
| Phone | 202 828 0850 |
| Web | https://www.danaher.com |
Ellis joins Danaher from Medtronic, plc., where he served as General Counsel of the company $8 billion global Restorative Therapies Group. Prior to Medtronic, Mr. Ellis worked at GE Healthcare as General Counsel of Monitoring Solutions and Services and, earlier, as Chief Compliance Officer.
Danaher Management Efficiency
The company has return on total asset
(ROA) of
0.0648 % which means that it generated a profit of $0.0648 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.1513 %, meaning that it generated $0.1513 on every $100 dollars invested by stockholders. Danaher's management efficiency ratios could be used to measure how well Danaher manages its routine affairs as well as how well it operates its assets and liabilities.
Danaher has accumulated 19.09
B in total debt with debt to equity ratio
(D/E) of 0.48, which is about average as compared to similar companies. Danaher has a current ratio of 2.21, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Danaher until it has trouble settling it off, either with new capital or with free cash flow. So, Danaher's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Danaher sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Danaher to invest in growth at high rates of return. When we think about Danaher's use of debt, we should always consider it together with cash and equity.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia. DANAHER CORPDRN operates under Diagnostics Research classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 67000 people. Danaher (DHER34) is traded on Sao Paulo Exchange in Brazil and employs 81,000 people.
Management Performance
Danaher Leadership Team
Elected by the shareholders, the Danaher's board of directors comprises two types of representatives: Danaher inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Danaher. The board's role is to monitor Danaher's management team and ensure that shareholders' interests are well served. Danaher's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Danaher's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rainer Blair, President, Chief Executive Officer, Director | |
| Angela Lalor, Senior Vice President - Human Resources | |
| Pardis Sabeti, Independent Director | |
| William King, Senior Vice President - Strategic Development | |
| Matthew McGrew, Chief Financial Officer, Executive Vice President | |
| Thomas Joyce, President, Chief Executive Officer, Director | |
| Mitchell Rales, CoFounder Director | |
| JoseCarlos GutierrezRamos, Senior Vice President Chief Scientific Officer | |
| John Schwieters, Independent Director | |
| Linda Filler, Lead Independent Director | |
| Teri ListStoll, Independent Director | |
| Daniel Raskas, Senior Vice President - Corporate Development | |
| Daniel Comas, CFO, Executive Vice President | |
| Elias Zerhouni, Independent Director | |
| Brian Ellis, Senior Vice President, Chief Compliance Officer, General Counsel | |
| Raymond Stevens, Independent Director | |
| Jessica Mega, Independent Director | |
| Steven Rales, Chairman of the Board | |
| John Bedford, VP Relations | |
| Alan Spoon, Independent Director | |
| Robert Lutz, Senior Vice President Chief Accounting Officer | |
| Walter Lohr, Independent Director | |
| Christopher Bouda, Chief Officer | |
| Joakim Weidemanis, Executive Vice President | |
| Jennifer Honeycutt, Executive Vice President | |
Danaher Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Danaher a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Information and Resources on Investing in Danaher Stock
When determining whether Danaher is a strong investment it is important to analyze Danaher's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Danaher's
future performance.
For an informed investment choice regarding Danaher Stock, refer to the following important reports: Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Danaher. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
For information on how to trade Danaher Stock refer to our
How to Trade Danaher Stock guide.
You can also try the
ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Please note, there is a significant difference between Danaher's value and its price as these two are different measures arrived at by different means. Investors typically determine if Danaher is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Danaher's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.